Breaking News

Bioclinica Launches Post-Approval Research Division

Aims to streamline overall study resource requirements

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bioclinica has launched a new Post-Approval Research division as part of its Global Clinical Research business segment. Leveraging its technology expertise, the service aims to streamline overall study resource requirements, and is flexible, scalable and customizable. It offers full access to real-time study metrics and transparency for all stakeholders.   The Post-Approval Research operates a Program Coordinating Center (PCC) with dedicated research staff and provides global operational infra...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters